Trivium Point Advisory’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$274K Buy
+2,984
New +$261K 0.02% 312
2025
Q3
Sell
-4,383
Closed -$398K 354
2025
Q2
$398K Sell
4,383
-98
-2% -$8.95K 0.04% 255
2025
Q1
$420K Buy
4,481
+300
+7% +$26.9K 0.05% 245
2024
Q4
$380K Buy
4,181
+442
+12% +$42.2K 0.05% 255
2024
Q3
$341K Buy
3,739
+322
+9% +$32.8K 0.05% 259
2024
Q2
$332K Buy
+3,417
New +$315K 0.05% 240
2021
Q1
Sell
-19,844
Closed -$1.62M 200
2020
Q4
$1.62M Buy
19,844
+181
+0.9% +$15K 0.47% 75
2020
Q3
$1.52M Buy
19,663
+1,710
+10% +$130K 0.54% 66
2020
Q2
$1.32M Buy
17,953
+1,290
+8% +$91.6K 0.52% 70
2020
Q1
$1.17M Sell
16,663
-2,295
-12% -$162K 0.6% 66
2019
Q4
$1.3M Buy
18,958
+374
+2% +$25.5K 0.51% 91
2019
Q3
$1.31M Buy
18,584
+325
+2% +$23.6K 0.6% 82
2019
Q2
$1.31M Buy
18,259
+425
+2% +$30.2K 0.58% 82
2019
Q1
$1.22M Buy
17,834
+1,110
+7% +$71.7K 0.57% 81
2018
Q4
$995K Buy
+16,724
New +$1.05M 0.6% 79

Other funds holding CL

Trivium Point Advisory's CL Position: Q2 2026 in Review

Trivium Point Advisory opened a new position in Colgate-Palmolive (CL) in Q2 2026: 2,984 shares worth $274K. The stake represents 0.02% of the portfolio and ranks #312 among its holdings. This is a return to the name: Trivium Point Advisory previously reported a position in CL as recently as Q2 2025.

Trivium Point Advisory first reported a position in CL in Q4 2018 and has held it in 15 quarters since. The position peaked at $1.62M in Q4 2020. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Trivium Point Advisory held 2,984 shares of Colgate-Palmolive worth $274K as of Q2 2026.
  • Colgate-Palmolive was a new Trivium Point Advisory position in Q2 2026.
  • Colgate-Palmolive made up 0.02% of Trivium Point Advisory's portfolio in Q2 2026, its #312 holding.
  • Trivium Point Advisory first reported a position in Colgate-Palmolive in Q4 2018 and has held it in 15 quarters since.
  • Trivium Point Advisory's Colgate-Palmolive position peaked at $1.62M in Q4 2020.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Trivium Point Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.